candesartan has been researched along with nitroarginine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, I; Fujii, K; Goto, K; Kansui, Y | 1 |
| Imamura, T; Ishikawa, T; Nakayama, K; Nejishima, H | 1 |
| Itoh, T; Kajikuri, J; Mabuchi, Y; Suzuki, Y; Tada, T | 1 |
| Jandhyala, BS; Tallam, LS | 1 |
| Arima, T; Kamimura, R; Mifune, H; Miyahara, K; Nakamura, K; Sata, N; Suzuki, S; Tanaka, Y | 1 |
| Edvinsson, L; Malmsjö, M; Nilsson, E; Vikman, P; Wackenfors, A | 1 |
6 other study(ies) available for candesartan and nitroarginine
| Article | Year |
|---|---|
Bradykinin enhances sympathetic neurotransmission in rat blood vessels.
Topics: Adenosine Triphosphate; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Captopril; Cyclooxygenase Inhibitors; Drug Interactions; Excitatory Postsynaptic Potentials; In Vitro Techniques; Indomethacin; Male; Membrane Potentials; Mesenteric Arteries; Microelectrodes; Neuromuscular Junction; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Stimulation, Chemical; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles | 2002 |
Non-contribution of renin-angiotensin system to pressor response to N(G)-nitro-L-arginine in dogs.
Topics: Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradycardia; Bradykinin; Captopril; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Heart Rate; Injections, Intravenous; Male; Nitroarginine; Renin; Renin-Angiotensin System; Stereoisomerism; Tetrazoles | 2002 |
Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cell Membrane Permeability; Cyclic GMP; Enalaprilat; Endothelium, Vascular; In Vitro Techniques; Kinetics; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitroarginine; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Thiazepines; Vasodilation | 2003 |
Influence of plasma insulin levels on antinatriuretic and vasoconstrictor actions of angiotensin-II.
Topics: Angiotensin II; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diuresis; Drug Interactions; Enzyme Inhibitors; Ganglionic Blockers; Heart Rate; Hypoglycemic Agents; Insulin; Kidney; Natriuresis; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Streptozocin; Tetrazoles; Vasoconstrictor Agents | 2003 |
Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Heart; Male; Nitroarginine; Organ Size; Quinapril; Rats; Rats, Wistar; RNA, Messenger; Systole; Tetrahydroisoquinolines; Tetrazoles; Transcription, Genetic | 2003 |
Angiotensin II-induced vasodilatation in cerebral arteries is mediated by endothelium-derived hyperpolarising factor.
Topics: Adenosine Triphosphate; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apamin; Benzimidazoles; Biological Factors; Biphenyl Compounds; Cerebral Arteries; Charybdotoxin; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Male; Neurotoxins; Nitric Oxide Synthase; Nitroarginine; Pyridines; Rats; Rats, Sprague-Dawley; Serotonin; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 2006 |